Role of S-100β in stroke

Area of Science:

• Biochemistry
• Neurology
• Clinical Diagnostics

Background:

• S-100β protein is a marker associated with various acute and chronic conditions, including head injury, stroke, and tissue damage.
• Elevated serum S-100β levels correlate with the extent of tissue damage, particularly observed in cases of brain damage or stroke.
• Previous studies suggest S-100β has clinical value in stroke diagnosis and prognosis, as it rises in peripheral blood during the acute phase.

Purpose of the Study:

• To evaluate the clinical utility of serum S-100β as a biomarker for stroke diagnosis and prognosis.
• To assess the diagnostic and prognostic discriminating ability of S-100β in stroke patients.

Main Methods:

• This study analyzed serum S-100β levels in patients with acute disorders, focusing on stroke cases.
• Levels of S-100β were correlated with the volume of tissue damage and clinical outcomes.
• Comparative analysis was performed to determine the diagnostic and prognostic accuracy of S-100β.

Main Results:

• Serum S-100β levels were found to increase with the volume of tissue damage.
• Higher S-100β levels were consistently observed following brain damage and stroke.
• The S-100β biomarker showed elevation in peripheral blood during the acute phase of stroke.

Conclusions:

• Serum S-100β is a sensitive indicator of tissue damage, particularly in neurological events like stroke.
• While elevated S-100β levels are associated with stroke, their clinical usefulness in diagnosis and prognosis is limited by low discriminating ability.
• Further research may be needed to enhance the diagnostic and prognostic value of S-100β in stroke management.